Viewing Study NCT04055220

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:19 AM
Ignite Modification Date: 2026-01-28 @ 12:27 PM
Study NCT ID: NCT04055220
Status: RECRUITING
Last Update Posted: 2024-09-19
First Post: 2019-08-05
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas
Sponsor: Centre Leon Berard
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bone Sarcoma View
None Osteosarcoma View
None Ewing Sarcoma View
None Chondrosarcoma View
None Undifferentiated Pleomorphic Sarcoma View
None Leiomyosarcoma View
None Angiosarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Maintenance therapy View
None First line therapy View
None Regorafenib View
None Randomization View
None Double-blinded View
None Placebo controlled View
None Relapse-free survival View
None Time to treatment failure View
None Overall survival View
None Quality of life View
None Compliance View
None Bone sarcoma View
None Osteosarcoma View
None Efficacy View
None Complete response View
None Tyrosine kinase inhibitor View
None Multi-target inhibitor View
None Safety View